Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
NPJ Breast Cancer|July 13, 2023
RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancerMelinda Magna, Gyong Ha Hwang, Alec McIntosh, et al.Cell Transplantation|June 30, 2009
Percutaneous cell delivery into the heart using hydrogels polymerizing in situTimothy P Martens, Amandine F G Godier, Jonathan J Parks, et al.Cancer|January 12, 2019
The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatmentChloe J Taub, Marc E Lippman, Barry I Hudson, et al.Diabetes & Vascular Disease Research|April 7, 2010
Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic miceLoredana G Bucciarelli, Andreas Pollreisz, Moritz Kebschull, et al.Diabetes & Vascular Disease Research|November 25, 2005
RAGE and its ligands: a lasting memory in diabetic complications?Shi-Fang Yan, Ravichandran Ramasamy, Loredana G Bucciarelli, et al.Atherosclerosis|September 21, 2014
High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan StudyEduard Tiozzo, Hannah Gardener, Barry I Hudson, et al.Atherosclerosis|February 15, 2011
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS)Barry I Hudson, Yeseon Park Moon, Anastasia Z Kalea, et al.Stroke|May 12, 2016
Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness: The Northern Manhattan StudyEduard Tiozzo, Hannah Gardener, Barry I Hudson, et al.Archives of Biochemistry and Biophysics|October 22, 2003
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disordersBarry I Hudson, Loredana G Bucciarelli, Thoralf Wendt, et al.The Journal of Clinical Investigation|December 15, 2007
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- miceEvis Harja, De-xiu Bu, Barry I Hudson, et al.Pageof 5